Cochlear Valuation
| COH Stock | 262.28 1.37 0.53% |
At this time, the firm appears to be overvalued. Cochlear shows a prevailing Real Value of USD230.8 per share. The current price of the firm is USD262.28. Our model approximates the value of Cochlear from analyzing the firm fundamentals such as return on equity of 0.2, and Profit Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cochlear's price fluctuation is very steady at this time. Calculation of the real value of Cochlear is based on 3 months time horizon. Increasing Cochlear's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Cochlear's intrinsic value may or may not be the same as its current market price of 262.28, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 262.28 | Real 230.8 | Hype 258.26 | Naive 272.03 |
The intrinsic value of Cochlear's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cochlear's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cochlear helps investors to forecast how Cochlear stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cochlear more accurately as focusing exclusively on Cochlear's fundamentals will not take into account other important factors: Cochlear Total Value Analysis
Cochlear is currently forecasted to have takeover price of 17.02 B with market capitalization of 17.15 B, debt of 243.7 M, and cash on hands of 555.5 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cochlear fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
17.02 B | 17.15 B | 243.7 M | 555.5 M |
Cochlear Investor Information
About 48.0% of the company shares are held by institutions such as insurance companies. The company recorded earning per share (EPS) of 5.64. Cochlear last dividend was issued on the 20th of March 2025. Based on the analysis of Cochlear's profitability, liquidity, and operating efficiency, Cochlear is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Cochlear Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cochlear has an asset utilization ratio of 82.26 percent. This implies that the Company is making USD0.82 for each dollar of assets. An increasing asset utilization means that Cochlear is more efficient with each dollar of assets it utilizes for everyday operations.Cochlear Ownership Allocation
Cochlear holds a total of 65.4 Million outstanding shares. 30% of Cochlear outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cochlear Profitability Analysis
The company reported the revenue of 2.26 B. Net Income was 356.8 M with profit before overhead, payroll, taxes, and interest of 1.74 B.About Cochlear Valuation
The stock valuation mechanism determines Cochlear's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Cochlear based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cochlear. We calculate exposure to Cochlear's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cochlear's related companies.Additional Tools for Cochlear Stock Analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.